Brief: Graphite Bio Reports Q4 Loss Per Share $0.35

LENZ Therapeutics

21/03/2022 13:45

March 21 (Reuters) - Graphite Bio Inc  GRPH.O :
    * GRAPHITE BIO REPORTS RECENT BUSINESS PROGRESS AND FOURTH
QUARTER
AND FISCAL YEAR 2021 FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.35
    * CASH RUNWAY EXTENDED INTO Q4 OF 2024
    * Q4 EARNINGS PER SHARE VIEW $-0.30 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw3KScv6a 
Further company coverage:  GRPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))